X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Experimental and Therapeutic Medicine

期刊標題檢索 EXP THER MED 最新評論: Do you need to provide the original data? (2024-09-24)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Experimental and Therapeutic Medicine]您好,您是該頁面的第 233511 位訪客。

期刊簡介
期刊名稱Experimental and Therapeutic Medicine Experimental and Therapeutic Medicine
LetPub Score
4.3
50 ratings
Rate

Reputation
3.2

Influence
4.2

Speed
8.5

期刊簡稱EXP THER MED
ISSN1792-0981
h-index33
CiteScore
CiteScoreSJRSNIPCiteScore Rank
1.500.0000.000
Subject fieldQuartilesRankPercentile
Category: Immunology and Microbiology
Subcategory: Immunology and Microbiology (miscellaneous)
Q3 / 4
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q148 / 191

自引率 (2023-2024)4.20%自引率趨勢
掲載範囲
官方網站https://www.spandidos-publications.com/etm/
在線稿件提交https://www.spandidos-publications.com/login
開放訪問No
出版商SPANDIDOS PUBL LTD
主題領域MEDICINE, RESEARCH & EXPERIMENTAL
出版國/地區GREECE
發行頻率
創刊年2010
每年文章數562每年文章數趨勢
黃金OA百分比99.56%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ3106/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1792-0981%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1.3 Month(s)
競爭力 *來自作者的數據: About 75%
參考鏈接
相關期刊 【Experimental and Therapeutic Medicine】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    MMWR Recommendations and ReportsH-index: 0

    CiteScore: 36.00
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    學科內最受檢索的期刊 頁面查看次數
    Frontiers in Pharmacology1983297
    PHARMACEUTICAL BIOLOGY1960613
    BIOMATERIALS1284929
    Oncogenesis905776
    Cancer Medicine758347
    MEDICINE674822
    JOURNAL OF ETHNOPHARMACOLOGY646431
    Oncology Letters559180
    BIOMEDICINE & PHARMACOTHERAPY503847
    Frontiers in Immunology494044
  •  

    Experimental and Therapeutic Medicine Experimental and Therapeutic Medicine
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/41)
  [Experimental and Therapeutic Medicine] 的評論撰寫評論
作者: 元枫mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-24 18:50:46 評論於
Do you need to provide the original data?
(0) 讚! | 元枫mio

作者: 兰花涵亦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-20 21:18:12 評論於
The methods required by the article are very detailed, and if there are any areas that are not detailed enough at the beginning, they need to be revised until the editor is satisfied before assigning reviewers.
(0) 讚! | 兰花涵亦

作者: 兰花涵亦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-20 13:23:19 評論於
Receive in a few months.
(0) 讚! | 兰花涵亦

作者: 白云爱成


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-07 19:54:54 評論於
Overall, the magazine is quite professional, with editors reviewing and editing the articles multiple times to improve their quality. However, the review process can be quite lengthy, taking around 5 months for the first review. If you are not in a hurry, you can submit your work
(0) 讚! | 白云爱成

作者: scut@Alexander


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-11 14:40:03 評論於
How much is the layout fee for this magazine?
(0) 讚! | scut@Alexander

作者: Ziyang666


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-28 10:50:30 評論於
This journal requests 5 recommended reviewers. Will they choose the reviewers I recommend, or will the system allocate them on its own?
(0) 讚! | Ziyang666

作者: 温斯顿弗朗西斯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-22 13:41:04 評論於
I suggest to withdraw the submission for editing, I have already revised it. Damn, it's really frustrating
(0) 讚! | 温斯顿弗朗西斯

作者: 日光半菡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-17 23:55:41 評論於
Warning, what should we do?
(0) 讚! | 日光半菡

作者: xx


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-01 21:13:56 評論於
It's too slow, it's been half a month and there's still no news
(0) 讚! | xx

作者: 气甲胜换


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-25 21:33:22 評論於
Oh, really? I thought you accepted it
(0) 讚! | 气甲胜换

作者: 苍风悦宜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-23 23:28:08 評論於
Research focus: Sharing of basic research experience: Particularly bad, after receiving it, it was repeatedly revised according to the requirements of the journal, and it has been in production for a long time. Really urgent, so I sent an email to inquire, only to receive a rejection email. It's really disappointing. To be honest, even a journal with ranking of level 4 also affects oneself, but don't waste time on such journals
(0) 讚! | 苍风悦宜

作者: 月河啸天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-22 13:10:48 評論於
Do reviewers request raw data for all experiments including PCR?
(0) 讚! | 月河啸天

作者: 京城芳洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-26 18:02:10 評論於
Bank remittance can be traced currently
(0) 讚! | 京城芳洲

作者: 韶容三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-22 22:06:55 評論於
How much is the layout fee?
(0) 讚! | 韶容三岁啦

作者: 东京乙巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-21 17:08:57 評論於
How did you pay the page fee? Can it be searched on WOS?
(0) 讚! | 东京乙巳

作者: 南川云娴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-14 10:48:55 評論於
Receive your lucky blessing
(0) 讚! | 南川云娴

作者: 南川云娴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-12 20:47:46 評論於
Was the rejection because the similarity rate was too high after receiving?
(0) 讚! | 南川云娴

作者: 京城芳洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-09 18:13:05 評論於
Please translate the following passage into English and Japanese, and label them as ":" and ":"
(0) 讚! | 京城芳洲

作者: 绿旋来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-08 21:54:14 評論於
Are you using the first payment method or the second payment method?
(0) 讚! | 绿旋来了

作者: 京城芳洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-01 19:08:41 評論於
Currently cannot be indexed
(0) 讚! | 京城芳洲

作者: 绿旋来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-29 19:26:32 評論於
Received online, how long?
(0) 讚! | 绿旋来了

作者: freefate


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-28 09:05:48 評論於
Either reject or accept, I have to do it
(0) 讚! | freefate

作者: 京城芳洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-25 18:00:55 評論於
I have also been proofread by other companies and have already accepted it. It should not affect
(0) 讚! | 京城芳洲

作者: 筑阳云水


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-23 14:30:42 評論於
After reading the comments, I realized that my revisions were done by another company. Am I doomed to fail already? Just waiting to be rejected
(0) 讚! | 筑阳云水

作者: 京城芳洲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-23 12:09:00 評論於
The external audit took one month and 11 days, which is still considered quite fast
(0) 讚! | 京城芳洲

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/41)

開始撰寫 [Experimental and Therapeutic Medicine] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*